OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Kim Nichols Shares New Guideline on Genetic Testing for Childhood Cancer Survivors

Pharma CEOs Meet in New York: What's at Stake for Cancer Drugs?

ESMO 2026 Reshapes Metastatic Breast Cancer Treatment: ADCs Move Into First Line as Biomarkers Guide New Strategies

SABR Versus Surgery in Early-Stage NSCLC: New JCO Study Supports Surgical Resection, With Important Questions for Older Patients

UNICORN Phase 2: Neoadjuvant Botensilimab Plus Balstilimab Shows Promising Activity in pMMR and dMMR Colon Cancer

Oncology News, Insights, Stories by OncoDaily

Agenus
Not To Miss

Agenus Reports 51% 18-Month Survival With BOT+BAL in MSS Colorectal Cancer

SIOG 2026
Not To Miss

SIOG 2026: 15 Posts Not to Miss from the Annual Conference in Valencia

Cesaltina Lorenzoni
Voices

Cesaltina Lorenzoni: Cancer Care Challenges in African Conflict Zones at LGCW 2026

Genmab’s Phase 3 LiGeR-HN1 Trial Met Primary Endpoints of Overall Survival and Response Rate in HNSCC

Supermodel Lara Stone Reveals Breast Cancer Diagnosis at 42

Spain Train Crash: Remembering Seven Scientists and Healthcare Professionals Among the Victims

Maira Caleffi on a Lifetime in Cancer Advocacy: ‘I Do One Thing, Many Branches’”

The LIFT Trial: Proving the Power of Embedded Financial Navigators in Rural and Urban Oncology

Health Policy Watch Examines Gevorg Tamamyan’s WHO Bid

From TAILORx to OPTIMA: Genomic Testing Expands Chemotherapy De-escalation in Higher-Risk HR-Positive Breast Cancer

Voices
Sanam Loghavi

Sanam Loghavi: Thanks to the Incredible Faculty Who Shared Their Expertise at Women In Hematology

Amanda Pullinger: Exploring Advances in Gastric Cancer Care at National Cancer Center Korea

Matthew Lunning: Amazing Opportunity to Give the Dr. Herzig Memorial Lecture

Giovanni Nigita: Bridging Molecular Data and Clinical Decisions at ISLB2026

Mina Sedrak: UCLA Opens Clinical Research Supervisor Position in Cancer and Aging

Runcie Chidebe: AI-Generated Cancer Education Research Featured at the 2026 GSA Annual Meeting

Olubukola Ayodele: LGCW 2026 - Turning Conversations Into Meaningful Action

FDA Approvals
Amivantamab

After a Decade Without a New Option, FDA Approves Amivantamab for Head and Neck Cancer

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

ESTRO Course: Artificial Intelligence in Radiotherapy Clinical Practice

European Society for Radiotherapy and Oncology (ESTRO)

09 Nov
Artificial Intelligence in Radiotherapy

27th Annual IPOS World Congress

International Psycho-Oncology Society (IPOS)

09 Nov
IPOS

SITC Computational Immuno-Oncology – AI Prediction of TCR-Antigen Binding

Society for Immunotherapy of Cancer

09 Nov
TCR-Antigen Binding

ESMO Congress Highlights Webinar – Gastrointestinal Cancers 2026

European Society For Medical Oncology (ESMO)

09 Nov
Gastrointestinal Cancers

ACCC Oncology Reimbursement Meeting - Providence

Association of Cancer Care Centers (ACCC)

10 Nov
ACCC Oncology

ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona

European Society For Medical Oncology (ESMO)

11 Nov
Brain Metastases

44th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow

Physicians’ Education Resource

11 Nov
44th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow

AACR Frontiers in Cancer Science 2026

American Association for Cancer Research

11 Nov
Cancer Science 2026

The AONN+ Annual Navigation and Survivorship Conference 2026

Academy of Oncology Nurse & Patient Navigators (AONN+)

11 Nov
AONN+

The Milken Institute Future of Health Summit 2026

Milken Institute

11 Nov
Future of Health Summit

SPCC Webinar: Real-World AI and Human–AI Collaboration in Oncology

Sharing Progress in Cancer Care (SPCC)

11 Nov
SPCC

Mayo Clinic Cardio-Oncology Update 2026

Mayo Clinic

12 Nov
Cardio-Oncology Update

Immune-oncology
Professor Gianluca Franceschini on Surgical De-escalation: Rethinking Breast Surgery in the Immunotherapy Era

Professor Gianluca Franceschini on Surgical De-escalation: Rethinking Breast Surgery in the Immunotherapy Era

10 Must-Read Posts in Immuno-Oncology This Week

Tarlatamab: Mechanism, Neurotoxicity, and the Next Chapter in SCLC Treatment

KEYFORM-007: Dual PD-1/LAG-3 Blockade in MSS Colorectal Cancer

Agentic AI for Immune-Related Adverse Event Detection in Cancer Immunotherapy

Can the Tumor’s Own B Cells Reveal the Next Immunotherapy Target?

ESMO 2026: The Key Pembrolizumab Trials to Know

Gastrointestinal-Oncology
UNICORN

UNICORN Phase 2: Neoadjuvant Botensilimab Plus Balstilimab Shows Promising Activity in pMMR and dMMR Colon Cancer

Agenus Reports 51% 18-Month Survival With BOT+BAL in MSS Colorectal Cancer

ABC-06 Trial: Prognostic Tumour Markers and Quality of Life With Second-Line FOLFOX in Advanced BTC

PRECEDE Study: Pancreatic Imaging Findings During Surveillance in BRCA1, BRCA2, ATM, and PALB2 Heterozygotes

Advanced Biliary Tract Cancer: Real-World Outcomes of First-Line Chemoimmunotherapy and Subsequent Targeted Therapy

NICHE-2: Long-Term Survival Outcomes With Neoadjuvant Immunotherapy in dMMR Colon Cancer

UNICORN Challenges Immunotherapy Resistance in MSS Colon Cancer

Breast-Oncology
Pembrolizumab

Pembrolizumab Achieves 70.8% Pathological Complete Response in Early TNBC: French Real-World Study Examines Treatment Delivery and Safety

ESMO 2026 Reshapes Metastatic Breast Cancer Treatment: ADCs Move Into First Line as Biomarkers Guide New Strategies

DESTINY-Breast09 Redefines First-Line HER2-Positive Breast Cancer: Balancing Efficacy, Safety, and Treatment Selection

From TAILORx to OPTIMA: Genomic Testing Expands Chemotherapy De-escalation in Higher-Risk HR-Positive Breast Cancer

Neoadjuvant Carboplatin Improves Event-Free Survival in Early TNBC: Pooled Analysis of Three Randomized Trials Strengthens the Evidence

SABCS 2026: The Top 10 Breast Cancer Studies to Watch for Potential Practice-Changing Results

Trastuzumab Deruxtecan Secures EU Approval for Residual HER2-Positive Early Breast Cancer Following DESTINY-Breast05 Survival-Free Disease Benefit

Lung-Oncology
NSCLC

SABR Versus Surgery in Early-Stage NSCLC: New JCO Study Supports Surgical Resection, With Important Questions for Older Patients

Small Cell Lung Cancer in Algeria in 2026: A Chemosensitive Disease That Leaves Little Room for Delay

Perioperative Ivonescimab Shows Promising Pathological Responses in Resectable NSCLC: Phase II Trial Reports 70.1% MPR and 50.7% pCR

LungÕ 2026: Integrating Care and Advancing Treatment for Locally Advanced Lung Cancer

Tarlatamab-Associated Neurotoxicity in SCLC: New Study Identifies TIAN in Patients With Brain Metastases

Neoadjuvant Immunotherapy Linked to Improved Five-Year Survival in Resected NSCLC: Real-World Study Supports Long-Term Benefit Without Increased Surgical Morbidity

Biomarker Landscape of ADCs and Bispecific Antibodies in Lung Cancer: The 2026 Clinical Trial Evidence and Future of Precision Treatment

OncoDaily TV
Dr Gevorg Tamamyan

Dr Gevorg Tamamyan Welcomes Prof Cesaltina Lorenzoni, President of AORTIC, to the International Advisory Board of WHO Director-General Campaign

Dr Gevorg Tamamyan

Mongolia’s Former Minister of Health Dr Chinburen Jigjidsuren Will Join the International Advisory Board of Dr Gevorg Tamamyan’s WHO DG Campaign

Rachel Purcell

Rachel Purcell Highlights New Zealand’s Nationwide Exercise Program for Bowel Cancer Patients

Alicia Fong

Alicia Fong: Exploring the Role of AI in Cancer Detection and Treatment

Dr Gevorg Tamamyan

“Stronger Regions, Stronger Countries…” – Dr Gevorg Tamamyan

Rejin Kebudi

“Diligent, Intelligent, Capable of Reaching Many Colleagues Globally ” – Rejin Kebudi, General Secretary of the International Society of Pediatric Oncology, about Dr Gevorg Tamamyan Upon His WHO DG Candidacy

Dr. Gevorg Tamamyan

“One of the Most Amazing and Truly Legendary Oncologists of Our Time” – Dr. Gevorg Tamamyan on Dr. Julie Gralow, Chief Medical Officer of ASCO

Dr Gevorg Tamamyan

“I Still Remember His Mentees That Spoke So Highly of Him… Having a Vision Means Investing in People That Will Make a Difference For the Years to Come” – Albanian Hematologist Liri Seraj Supports Dr Gevorg Tamamyan as WHO DG Candidate

World Radiotherapy Awareness Day

12 Countries, One Vision for the Future of Radiotherapy – World Radiotherapy Awareness Day

Bishal Gyawali

Erika Ruiz-Garcia Joins Bishal Gyawali on Grounded In Groundshot Podcast

Dr Gevorg Tamamyan

“One Planet is Not Enough For His Vision” – Dr Amalya Sargsyan Celebrates Her Mentor Dr Gevorg Tamamyan

Dr Gevorg Tamamyan

Renowned Surgeon and Inventor of Abraxane, Philanthropist Dr Patrick Soon-Shiong Endorses Dr Gevorg Tamamyan as WHO Director-General Candidate

Not To Miss
The AstraZeneca Foundation Awards Over $1.1 Million to Expand Community Healthcare Access

The AstraZeneca Foundation Awards Over $1.1 Million to Expand Community Healthcare Access

Agenus Reports 51% 18-Month Survival With BOT+BAL in MSS Colorectal Cancer

LungÕ 2026: Global Experts Examine the Changing Landscape of Lung Cancer Care

SIOG 2026: 15 Posts Not to Miss from the Annual Conference in Valencia

Genmab’s Phase 3 LiGeR-HN1 Trial Met Primary Endpoints of Overall Survival and Response Rate in HNSCC

Geneva Health Files Interviews Gevorg Tamamyan on WHO Reform and Global Health Leadership

Reed Jobs’ Yosemite Raises $350 Million to Support Cancer Research

OncoGrants
CAP Foundation

CAP Foundation Equity and Equality in Diagnostics Award

Oral Cancer

AGD Foundation Oral Cancer Awareness and Screening Grants 2027

Binaytara

Binaytara Implementation Science Research Awards 2027

Early-Career Scholar

AACR Early-Career Scholar in the Field of Cancer Research Awards 2027

Emerging Technologies

NCI Advanced Development and Validation of Emerging Technologies for Cancer Research 2026

AABB Foundation

AABB Foundation Early-Career Scientific Research Grants 2027

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Chandler Park

Chandler Park

Oncologists Location Louisville, USA
Luciano Mutti

Luciano Mutti

Oncologists Location L’Aquila, Italy
Rachna Shroff

Rachna Shroff

Oncologists Location Tucson, USA
Kathleen Schmeler

Kathleen Schmeler

Oncologists Location Houston, USA
Etienne Brain

Etienne Brain

Oncologists Location Saint-Cloud, France
Shui Yen Soh

Shui Yen Soh

Oncologists Location Singapore, Singapore
Balu Vijayan

Balu Vijayan

Oncologists Location Kulasekharam, India
Sandy Carmona Lozano

Sandy Carmona Lozano

Oncologists Location Pueblo Libre, Peru

Drugs Atlas
Isatuximab (Sarclisa, Sarclisa Escena): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Isatuximab-irfc (Sarclisa, Sarclisa Escena) Nov 8, 2026 1:29 am
Daratumumab (Darzalex, Darzalex Faspro): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Daratumumab (Darzalex, Darzalex Faspro) Nov 8, 2026 1:28 am
Bevacizumab (Avastin): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Bevacizumab (Avastin) Nov 6, 2026 4:49 pm
Panitumumab (Vectibix): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Panitumumab (Vectibix) Nov 5, 2026 1:18 pm
Cetuximab (Erbitux): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Cetuximab (Erbitux) Nov 5, 2026 1:14 pm
Margetuximab (Margenza): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Margetuximab (Margenza) Nov 5, 2026 1:09 pm
Pertuzumab (Perjeta): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Pertuzumab (Perjeta) Nov 3, 2026 9:23 am
Trastuzumab (Herceptin): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Trastuzumab (Herceptin) Nov 2, 2026 5:11 pm
Ofatumumab (Arzerra, Kesimpta): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Ofatumumab (Arzerra, Kesimpta) Nov 1, 2026 1:25 am
Obinutuzumab (Gazyva): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Obinutuzumab (Gazyva; Gazyvaro) Nov 1, 2026 1:23 am

OncoDaily Magazine

New Paper Alert
Ted Yanagihara

Ted Yanagihara: Assessing the Impact of PROSPECT and ESOPEC on GI Radiation Treatment Patterns

Aung Naing

Aung Naing: Reflecting on the Immune Checkpoint Inhibitor Journey and Its Impact on Patient Care

Kim Nichols

Kim Nichols Shares New Guideline on Genetic Testing for Childhood Cancer Survivors

Achille Manirakiza

Achille Manirakiza: A Prehistoric BRCA1 Founder Variant in Rwanda

Luis Álvarez-Vallina

Luis Álvarez-Vallina’s STAb-T Research Takes the Spotlight in Advanced Science

Jia Liu

Jia Liu: Are We Measuring the Full Benefit of ADCs in Cancer Treatment?

OncoDaily Medical Journal

GU Oncology

10.69690/ODMJ-001-1026-8269

Psychosocial burden and lifestyle impact in patients with renal cell carcinoma: a patient-reported outcomes analysis
Original Research

Pediatric Oncology

10.69690/ODMJ-001-1026-8309

Limited Prognostic Value of Baseline Curie Score in Children with High-Risk Neuroblastoma Treated with Contemporary Multi-modal Therapy: A Single-Center Retrospective Cohort Study
Original Research

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews